Heterophile Antibodies Indicate Progression of Autoimmunity in Human Type 1 Diabetes Mellitus Before Clinical Onset

References

• Bottazzo G F, Florin‐Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendo‐crine deficiencies. Lancet 1974; 2: 1279–1282
   PubMed Web of Science ®Google Scholar
• Palmer J P, Asplin C M, Clemons P, Lyen K, Tatpati O, Raghu P K, Paquette T L. Insulin antibodies in insulin‐dependent diabetics before insulin treatment. Science 1983; 222: 1337–1339
   PubMed Web of Science ®Google Scholar
• Baekkeskov S, Aanstoot H, Christgau S, Reetz A, Solimena M S, Cascalho M, Folli F, Richter‐Olsen H, DeCamilli P. Identification of the 64 K autoantigen in insulin dependent diabetes as the GABA‐synfhesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–156
   PubMed Web of Science ®Google Scholar
• Christie M R, Genovese S, Cassidy D, Bosi E, Brown T J, Lai M, Bonifacio E, Bottazzo G F. Antibodies to islet 37 k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 1994; 43: 1254–1259
   PubMed Web of Science ®Google Scholar
• Verge C F, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Chase H P, Eisenbarth G S. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. Journal of Autoimmunity 1996; 9: 379–83
   PubMed Web of Science ®Google Scholar
• Verge C F, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson R A, Chase H P, Eisenbarth G S. Prediction of type I diabetes in first‐degree relatives using a combination of insulin, GAD, and ICA512bdc/IA‐2 autoantibodies. Diabetes 1996; 45: 926–933
   PubMed Web of Science ®Google Scholar
• Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengard J, Kesaniemi Y A. Concordance for type 1 (insulin‐dependent) and type 2 (non‐insulin‐dependent) diabetes mellitus in a population‐based cohort of twins in Finland. Diabetologia 1992; 35: 1060–1067
   PubMed Web of Science ®Google Scholar
• Wilson S B, Kent S C, Patton K T, Orban T, Jackson R A, Exley M, Porcelli S, Schatz D A, Atkinson M A, Balk S P, Strominger J L, Hafler D A. Extreme Thl bias of invariant Vct24JaQ T cells in type 1 diabetes. Nature 1998; 391: 177–181
   PubMed Web of Science ®Google Scholar
• Redondo M J, Gottlieb P A, Motheral T, Mulgrew C, Rewers M, Babu S, Stephens E, Wegmann D R, Eisenbarth G S. Het‐erophile anti‐mouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for type 1A diabetes. Diabetes 1999; 48: 2166–2170
   PubMedGoogle Scholar
• She J X, Ellis T M, Wilson S B, Wasserfall C H, Marron M, Reimsneider S, Kent S C, Hafler D A, Neuberg D S, Muir A, Strominger J L, Atkinson M A. Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes. Proceedings of the National Academy of Sciences USA 1999; 96: 8116–8119
   PubMedGoogle Scholar
• Bonifacio E, Bingley P J, Shattock M, Dean B M, Dunger D, Gale E A M, Bottazzo G F. Quantitative islet cell antibody measurement assists in the prediction of insulin‐dependent diabetes. Lancet 1990; 335: 147–149
   PubMed Web of Science ®Google Scholar
• Boitard C, Bonifacio G, Bottazzo G F, Gleichman H, Molenaar J. Immunology and Diabetes Workshop: report on the third international (stage 3) workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 1988; 31: 451–452
   PubMedGoogle Scholar
• Vardi P, Dib S A, Tuttleman M, Connelly J E, Grinbergs M, Rabizadeh A, Riley W J, Maclaren N K, Eisenbarth G S, Soe‐ldner J S. Competitive insulin autoantibody RIA: Prospective evaluation of subjects at high risk for development of Type I diabetes mellitus. Diabetes 1987; 36: 1286–1291
   PubMed Web of Science ®Google Scholar
• Grubin C E, Daniels T, Toivola B, Landin‐Olsson M, Hago‐pian W A, Li L, Karlsen A E, Boel E, Michelsen B, Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform‐specific glutamic acid decarboxylase antibodies in childhood I. D. D. M. Diabetologia 1994; 37: 344–350
   PubMed Web of Science ®Google Scholar
• Payton M A, Hawkes C J, Christie M R. Relationship of 37,000 and 40,000‐M tryptic fragment of islet antigens in insulin dependent diabetes to the protein tyrosine phos‐phatase‐like molecule IA‐2 (ICA 512). Journal of Clinical Investigation 1995; 96: 1506–1511
   PubMed Web of Science ®Google Scholar
• Boscato L M, Stuart M C. Incidence and specificity of interference in two‐site immunoassays. Clinical Chemistry 1986; 32: 1491–1495
   PubMed Web of Science ®Google Scholar
• Boscato L M, Stuart M C. Heterophilic antibodies: a problem for all immunoassays. Clinical Chemistry 1998; 34: 27–33
   Google Scholar
• Levinson S S. Antibody multispecificity in immunoassay interference. Clinical Biochemistry 1992; 25: 77–87
   PubMedGoogle Scholar
• Borretzen M, Natvig J B, Thompson K M. Heterogeneous RF structures between and within healthy individuals are not related to HLA DRB 10401. Molecular Immunology 1997; 34: 929–938
   PubMedGoogle Scholar
• Kaplan I V, Levinson S S. When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen. Clinical Chemistry 1999; 45: 616–618
   PubMed Web of Science ®Google Scholar
• Agnello V, Arbetter A, Ibanez de Kasep G, Powell R, Tan E M, Joslin F. Evidence for a subset of rheumatoid factors that cross‐react with DNA‐histone and have a distinct cross‐idiotype. Journal of Experimental Medicine 1980; 151: 1514–1527
   PubMed Web of Science ®Google Scholar
• Prince A M, Brotman B, Jass D, Dcram H. Specificity of the direct solid‐phase radioimmunoassay for detection of hepati‐tis‐B antigen. Lancet 1973; 1: 1346–1350
   PubMed Web of Science ®Google Scholar
• Hedenborg G, Pettersson T, Carlstrom A. Heterophilic antibodies causing falsely raised thyroid‐stimulating‐hormone result. Lancet 1979; 2: 755–755
   PubMed Web of Science ®Google Scholar
• Hunter W M, Budd P S. Circulating antibodies to ovine and bovine immunoglobulin in healthy subjects: a hazard for immunoassays. Lancet 1980; 2: 1136–1136
   PubMed Web of Science ®Google Scholar
• Carson D A, Chen P P, Fox R I, Kipps T J, Jirik F, Goldfien R D, Silverman G, Radoux V, Fong S. Rheumatoid factor and immune networks. Annual Review of Immunology 1987; 5: 109–126
   PubMed Web of Science ®Google Scholar
• Verge C F, Gianani R, Yu L, Pietropaolo M, Smith T, Jackson R A, Soeldner J S, Eisenbarth G S. Late progression to diabetes and evidence for chronic beta‐cell autoimmunity in identical twins of patients with type I diabetes. Diabetes 1995; 44: 1176–1179
   PubMedGoogle Scholar
• Nikoskelainen J, Hanninen P. Antibody response to Epstein‐Barr virus in infectious mononucleosis. Infection and Immunity 1975; 11: 42–51
   PubMed Web of Science ®Google Scholar
• Choy E H, Schantz A, Pitzalis C, Kingsley G H, Panayi G S. The pharmacokinetics and human anti‐mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti‐CD4 monoclonal antibody. British Journal of Rheumaetology 1998; 37: 801–802
   PubMedGoogle Scholar
• Clofent‐Sanchez G, Laroche‐Trainean J, Lucas S, Rispal P, Pellegrin J L, Nurden P, Nurden A. Incidence of anti‐mouse antibodies in thrombocytopenic patients with autoimmune disorders. Human Antibodies 1997; 8: 50–59
   PubMedGoogle Scholar
• Waller M, Pierce J C, Lee H M, Levinson H J. Humoral antibody responses following transplantation in man. Transplantation 1975; 19: 210–218
   PubMedGoogle Scholar
• Courtenay‐Luck N S, Epenetos A A, Winearls C G, Ritter M A. Preexisting human anti‐murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Research 1987; 47: 4520–4525
   PubMed Web of Science ®Google Scholar
• Sipe J D, Colten H R, Goldberger G, Edge M D, Tack B F, Cohen A S, Whitehead A S. Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary D. N. A. Biochemistry 1985; 24: 2931–2936
   PubMed Web of Science ®Google Scholar
• Maeda N. Nucleotide sequence of the haptoglobin and hap‐toglobin‐related gene pair. The haptoglobin‐related gene contains a retrovirus‐like element. Journal of Biological Chemistrym, 5(260)6698–6709
   Google Scholar
• Putnam F W, Liu Y S, Low T L. Primary structure of a human IgAl immunoglobulin. I. V. Streptococcal IgAl protease, digestion, Fab and Fc fragments, and the complete amino acid sequence of the alpha 1 heavy chain. Journal of Biological Chemistry 1979; 254: 2865–2874
   PubMedGoogle Scholar
• Flanagan J G, Lefranc M P, Rabbitts T H. Mechanisms of divergence and convergence of the human immunoglobulin alpha 1 and alpha 2 constant region gene sequences. Cell 1984; 36: 681–688
   PubMedGoogle Scholar
• Walter G, Tomlinson I M, Cook G P, Winter G, Rabbitts T H, Dear P H. HAPPY mapping of a YAC reveals alternative hap‐lotypes in the human immunoglobulin VH locus. Nucleic Acids Research 1993; 21: 4524–4529
   PubMedGoogle Scholar
• Eng J K, McCormick A L, Yates J R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. Journal of the American Society for Mass Spectometry 1994; 5: 976–989
   PubMed Web of Science ®Google Scholar